A Study of HDM2024 in Participants With Advanced Solid Tumors

Summary

The goal of this clinical trial is to learn if the study drug can work in advanced cancer patients. The main questions it aims to answer are: * Is the drug safe and tolerable ? * Does the drug exhibit antitumor activity ? Participants will receive the study drug once every three weeks, and imaging-based efficacy assessments will be performed every six weeks.

Timeline

Start

2026-04-10

Primary completion

2027-04-15

Completion

2028-12-28

Drugs

Indications